Catalent 1Q Revenues: $543.9 million (+23%) 1Q Earnings: $3.8 million (-17%) Comments: Softgel Technologies revenue was $219.7 million in the quarter, up 18%. Growth was primarily attributable to the February 2017 Accucaps acquisition, which contributed 14 percentage points. Drug Delivery Solutions revenue was $225.8 million, up 18% primarily driven by favorable demand for certain higher margin offerings, primarily U.S. operations for oral delivery platform, and increased volume from biologic...